chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Bone pain, Headache, Neck pain
Clinical narrative: Severe pain from right shoulder along upper back, up my neck to the bottom of my head.  Pain continues up the back of my head to the top of the rear of my skull.; Severe pain from right shoulder along upper back, up my neck to the bottom of my head.  Pain continues up the back of my head to the top of the rear of my skull.; Severe pain from right shoulder along upper back, up my neck to the bottom of my head.  Pain continues up the back of my head to the top of the rear of my skull.; Severe pain from right shoulder along upper back, up my neck to the bottom of my head.  Pain continues up the back of my head to the top of the rear of my skull.; Severe pain from right shoulder along upper back, up my neck to the bottom of my head.  Pain continues up the back of my head to the top of the rear of my skull.; This is a spontaneous report from a contactable consumer (patient). A 74-years-old male patient received BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, batch/lot number: EN6198), via an unknown route of administration in right arm on 09Mar2021 at 10:00 (at the age of 74-years-old) as dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. No known allergies. No other vaccine in four weeks. Yes, other medications in two weeks further not clarified. The patient received BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, batch/lot number: EL9269), via an unknown route of administration in left arm on 07Feb2021 at 09:00 (at the age of 74-years-old) as historical vaccine dose 1, single for COVID-19 immunisation. On 11Mar2021 at 16:15, the patient experienced severe pain from right shoulder along upper back, up my neck to the bottom of my head. Pain continues up the back of my head to the top of the rear of my skull. No COVID prior vaccination. No COVID tested post vaccination. It was unknown if treatment received for events. The outcome of events was unknown.  No Follow up attempts are possible. No further information is excepted.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Musculoskeletal discomfort, Pain, Pain in extremity, Vaccination site pain
Clinical narrative: I am in so much pain, with aches and joints/ Every joint is killing me.; My legs are throbbing; I am in so much pain, with aches and joints/ Every joint is killing me.; My back, I can't get comfortable; The arm that I got the shot is so sore; The arm that I got the shot is so sore; This is a spontaneous report from a contactable Other HCP (patient). A non-pregnant 51-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: not reported, expiry date: not reported, Age at vaccination: 51-year-old) via an unspecified route of administration in left arm on 11Mar2021 01:00 PM as DOSE 2, SINGLE for COVID-19 immunization. The patient medical history was included overweight, borderline diabetic. Concomitant medications included Clodian, omeprazole, venlafaxine. Historical vaccine included bnt162b2 via an unspecified route of administration in left arm on 19Feb2021 as Dose 1, SINGLE for COVID-19 immunization. On 12Mar2021 02:00 AM, patient experienced i am in so much pain, with aches and joints/ Every joint is killing me (joint pain and pain), my legs are throbbing, my back, I can't get comfortable, the arm that I got the shot is so sore (vaccination site pain and pain in arm). Facility type vaccine was workplace clinic. Treatment was received for the adverse event as Aleve. No covid prior vaccination. Covid was not tested post vaccination. No known allergies. The outcome of events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Eye swelling, Eyelid exfoliation, Eyelid pain, Psoriasis
Clinical narrative: I had a flare up of symptoms that have previously been diagnosed as psoriasis or maybe an allergic reaction; eyes swelled up and the skin around them became red, scaly and painful; eyes swelled up and the skin around them became red, scaly and painful; eyes swelled up and the skin around them became red, scaly and painful; This is a spontaneous report received from a contactable consumer or other non hcp. A 46-years-old non pregnancy female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: En6205) via an unspecified route of administration in Arm Left on 07Mar2021 16:00 (age at vaccination 46years old) as single dose for covid-19 immunisation. The patient was not pregnant at the time of vaccination. The patient did not have Known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient medical history was not reported. Concomitant medication(s) included lisdexamfetamine mesilate (VYVANSE) taken for an unspecified indication, start and stop date were not reported. Since the vaccination, the patient had not been tested positive for COVID-19. On 11Mar2021 at 04:00 the patient experienced i had a flare up of symptoms that have previously been diagnosed as psoriasis or maybe an allergic reaction, eyes swelled up and the skin around them became red, scaly and painful. Clinical course was reported as she had a flare up of symptoms that has previously been diagnosed as psoriasis or maybe an allergic reaction. she has never known for sure what it is. But 4 days after her first dose, her eyes swelled up and the skin around them became red, scaly, and painful. This has happened in the past and has never been definitively diagnosed. The patient did not receive any treatment for the adverse events. The clinical outcome of the event was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia
Clinical narrative: chills; low grade fever; headache; This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A 56-years-old non pregnant female patient received (not pregnant at the time of vaccination) bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine, Solution for injection), dose 2 via an unspecified route of administration, administered in arm left on 10Mar2021 11:00 (Batch/Lot Number: EN6206) as dose 2, single for covid-19 immunisation (at the age of 56-year-old). The patient medical history was reported as none. The concomitant medication(s) included vitamin d (VITAMIN D NOS) taken for an unspecified indication, start and stop date were not reported and OTC seasonal allergy medications. The patient had known allergies for Levaquin. The patient did not receive any other vaccines within 4 weeks prior to the covid 19 vaccine. The patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The patient had previously received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine, Solution for injection), dose 1 via an unspecified route of administration, administered in arm left on 17Feb2021 09:30 AM (Batch/Lot Number: EL9266) as dose 1, single for covid-19 immunization. On 11Mar2021 07:00 AM, after 18 hours of post vaccination, the patient experienced chills, low grade fever and headache. The patient not received treatment. The outcome of the events was recovered on an unknown date in 2021.  No follow-up attempts are possible. No further information is expected.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Pain in extremity
Clinical narrative: Shoulder and forearm ache and pain; Shoulder and forearm ache and pain; This is a spontaneous report received from a contactable consumer or other non hcp.A 86-years-old male patient received bnt162b2 (COMIRNATY,Batch/Lot Number: EN6200), via an unspecified route of administration, administered in Arm Left on 23Feb2021 14:00,at the age of 86 years old,as Dose number unknown,single for covid-19 immunization.Medical history included none from an unknown date and unknown if ongoing.There were no concomitant medications.  The patient experienced shoulder and forearm ache and pain, shoulder and forearm ache and pain on 24Feb2021 03:00.The patient had not received any other vaccine in 4 weeks.The patient had not received any other medications within 2 weeks.The patient was not diagnosed with covid prior vaccination and not tested post vaccination.The patient didn't receive any treatment for the event.The patient reported no allergy.The outcome of the event was not recovered.   No follow-up attempts are possible. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Chest X-ray, Chest discomfort, Dizziness, Headache
Clinical narrative: Within a day I began to feel pressure in my chest and was feeling like I could not get enough air; Also, at times it was/is difficult to talk; Slight headache; lightheadedness; This is a spontaneous report from a contactable consumer or other non hcp female consumer (patient). A 67-years-old female patient received BNT162b2 (CONMINTARY, Solution for injection, Lot No: EN6202), via an unspecified route of administration, administered in Arm Right on 04Mar2021 10:15 as 1st dose, single for covid-19 immunisation (Age at vaccination was 67 years).  Patient was pregnant at time of vaccination.  Medical history included autoimmune thyroiditis from an unknown date and unknown if ongoing, varicose vein from an unknown date and unknown if ongoing. Concomitant medication(s) included levothyroxine sodium (SYNTHROID) taken for an unspecified indication, start and stop date were not reported; liothyronine sodium (CYTOMEL) taken for an unspecified indication, start and stop date were not reported; loratadine (CLARITIN [LORATADINE]) taken for an unspecified indication, start and stop date were not reported; estradiol, estriol, estrone (TRIEST) taken for an unspecified indication, start and stop date were not reported; vitamin d3 (VITAMIN D3) taken for an unspecified indication, start and stop date were not reported. The patient previously took lamisil [terbinafine hydrochloride] and experienced drug hypersensitivity, tetanus vaccine and experienced drug hypersensitivity, betadine [povidone-iodine] and experienced drug hypersensitivity, gantrisine and experienced drug hypersensitivity.  The patient experienced within a day i began to feel pressure in my chest and was feeling like i could not get enough air, also, at times it was/is difficult to talk, slight headache, light headedness on 05Mar2021.  The patient underwent lab tests and procedures which included blood test: good   on Mar2021, chest x-ray: good   on Mar2021, oxygen saturation: good   on Mar2021.If other vaccine in four weeks was no.AE resulted in emergency room/department or urgent care. No, treatment was received. If covid prior vaccination was no. If covid tested post vaccination was unknown. Outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Oxygen saturation, Speech disorder
Clinical narrative: Within a day I began to feel pressure in my chest and was feeling like I could not get enough air; Also, at times it was/is difficult to talk; Slight headache; lightheadedness; This is a spontaneous report from a contactable consumer or other non hcp female consumer (patient). A 67-years-old female patient received BNT162b2 (CONMINTARY, Solution for injection, Lot No: EN6202), via an unspecified route of administration, administered in Arm Right on 04Mar2021 10:15 as 1st dose, single for covid-19 immunisation (Age at vaccination was 67 years).  Patient was pregnant at time of vaccination.  Medical history included autoimmune thyroiditis from an unknown date and unknown if ongoing, varicose vein from an unknown date and unknown if ongoing. Concomitant medication(s) included levothyroxine sodium (SYNTHROID) taken for an unspecified indication, start and stop date were not reported; liothyronine sodium (CYTOMEL) taken for an unspecified indication, start and stop date were not reported; loratadine (CLARITIN [LORATADINE]) taken for an unspecified indication, start and stop date were not reported; estradiol, estriol, estrone (TRIEST) taken for an unspecified indication, start and stop date were not reported; vitamin d3 (VITAMIN D3) taken for an unspecified indication, start and stop date were not reported. The patient previously took lamisil [terbinafine hydrochloride] and experienced drug hypersensitivity, tetanus vaccine and experienced drug hypersensitivity, betadine [povidone-iodine] and experienced drug hypersensitivity, gantrisine and experienced drug hypersensitivity.  The patient experienced within a day i began to feel pressure in my chest and was feeling like i could not get enough air, also, at times it was/is difficult to talk, slight headache, light headedness on 05Mar2021.  The patient underwent lab tests and procedures which included blood test: good   on Mar2021, chest x-ray: good   on Mar2021, oxygen saturation: good   on Mar2021.If other vaccine in four weeks was no.AE resulted in emergency room/department or urgent care. No, treatment was received. If covid prior vaccination was no. If covid tested post vaccination was unknown. Outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Dizziness, Fatigue, Headache
Clinical narrative: Severe body aches; chills; fatigue; headache; light headedness; sore throat; joint pain; This is a spontaneous report from a contactable other HCP (patient) reporting for herself. A 32-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: ENU199), via an unspecified route of administration, administered in Left arm on 10Mar2021 09:45 at the age of 32-years-old as dose 2, single for covid-19 immunisation. The patient's medical history was not reported. Concomitant medications included sertraline (SERTRALINE) taken for an unspecified indication, start and stop date were not reported; clonazepam (CLONAZEPAM) taken for an unspecified indication, start and stop date were not reported received in two weeks of vaccination. The patient previously took first dose of historical vaccine, bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EL9267), via an unspecified route of administration, administered in Left arm on 17Feb2021 at the age of 32-years-old as single dose for covid-19 immunisation. The patient previously took acetaminophen and experienced allergy. The patient did not receive other vaccine in four weeks of vaccination. The patient was not diagnosed with COVID-19 prior vaccination. The patient has not been tested for COVID-19 post vaccination. On 11Mar2021 at 01:00, the patient experienced Severe body aches, chills, fatigue, headache, light headedness, sore throat and joint pain. Adverse events resulted in Doctor or other healthcare professional office/clinic visit. No treatment was received for adverse events. The outcome of events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain
Clinical narrative: Severe body aches; chills; fatigue; headache; light headedness; sore throat; joint pain; This is a spontaneous report from a contactable other HCP (patient) reporting for herself. A 32-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: ENU199), via an unspecified route of administration, administered in Left arm on 10Mar2021 09:45 at the age of 32-years-old as dose 2, single for covid-19 immunisation. The patient's medical history was not reported. Concomitant medications included sertraline (SERTRALINE) taken for an unspecified indication, start and stop date were not reported; clonazepam (CLONAZEPAM) taken for an unspecified indication, start and stop date were not reported received in two weeks of vaccination. The patient previously took first dose of historical vaccine, bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EL9267), via an unspecified route of administration, administered in Left arm on 17Feb2021 at the age of 32-years-old as single dose for covid-19 immunisation. The patient previously took acetaminophen and experienced allergy. The patient did not receive other vaccine in four weeks of vaccination. The patient was not diagnosed with COVID-19 prior vaccination. The patient has not been tested for COVID-19 post vaccination. On 11Mar2021 at 01:00, the patient experienced Severe body aches, chills, fatigue, headache, light headedness, sore throat and joint pain. Adverse events resulted in Doctor or other healthcare professional office/clinic visit. No treatment was received for adverse events. The outcome of events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Swollen tongue, Urticaria
Clinical narrative: I had a tongue swelling for about an hour; Weak for a day and half, pretty weak; One hive twelve hours after getting it; This is a spontaneous report from a contactable consumer (patient). A 63-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EN6202, expiration date: 30Jun2021), via an unspecified route of administration on an unspecified date (at the age of 63 years) as dose 1, single for COVID-19 immunization. The patient medical history included allergy to Erythromycin, Cipro and then Levaquin. For Levaquin she had extreme reaction 10 years ago involving her windpipe and throat and she went to the ER. The patient's concomitant medications were not reported. On an unspecified date the patient said she had tongue swelling for about an hour, she had one hive twelve hours after getting the vaccine and then she was weak for a day and half, pretty weak. She also mentioned that she didn't have to go to the hospital for the reactions. She was just reporting the connection between the three medications she was allergic to, and the Pfizer vaccine called Polyethylene glycol (PEG) which was an ingredient in all. She was thinking that could be her problem and it could be for other people, so she was reporting it so that someone else may be helped by that information or so that more information can be gathered. She said was very happy to get the vaccine but due to the reaction she was afraid to get the second dose, one because of the reactions to PEG in the past. Patient mentioned she did not take any treatment but kept Benadryl close in case the reactions got worse. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Illness, Night sweats, Pain
Clinical narrative: Fever; chills; headache; body aches; night sweats; Felt very sick; This is a spontaneous report from a contactable consumer. A 71 year old elderly male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number, Expiry Date: not reported), via an unspecified route of administration, administered in left arm on 03Mar2021 at 09:30 as dose 1, single for covid-19 immunisation. Medical history included covid-19. He had Covid 3 months before vaccination. No known allergies. There were no concomitant medications. No other vaccine in four weeks. No other medications in two weeks. Covid not tested post vaccination. On 03Mar2021, the patient experienced fever, chills, headache, body aches, night sweats for a week. Symptoms lasted for over 48 hours. Worse than when he had Covid 3 months before. Felt very sick. He was afraid to take the next shot. The treatment not received for events. The outcome of events was recovered in Mar2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; chills; headache; body aches; night sweats; Felt very sick; This is a spontaneous report from a contactable consumer. A 71 year old elderly male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number, Expiry Date: not reported), via an unspecified route of administration, administered in left arm on 03Mar2021 at 09:30 as dose 1, single for covid-19 immunisation. Medical history included covid-19. He had Covid 3 months before vaccination. No known allergies. There were no concomitant medications. No other vaccine in four weeks. No other medications in two weeks. Covid not tested post vaccination. On 03Mar2021, the patient experienced fever, chills, headache, body aches, night sweats for a week. Symptoms lasted for over 48 hours. Worse than when he had Covid 3 months before. Felt very sick. He was afraid to take the next shot. The treatment not received for events. The outcome of events was recovered in Mar2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Muscle spasms, Ocular hyperaemia, Pyrexia, Tremor
Clinical narrative: Chills that night, shaking in bed at midnight for about 10 minutes - like a full body shiver that just kept going; Chills that night, shaking in bed at midnight for about 10 minutes - like a full body shiver that just kept going; Felt a kind of cramp or something in my neck at the time too; My right eye is very bloodshot, and has been since Sunday (07Mar2021)... still bloodshot, not sure it has improved.; Had a fever maybe starting that night, and that lasted til at least Monday night; This is a spontaneous report from a contactable consumer or other non-hcp (Patient). A 31-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection; Batch/Lot Number: Unknown, Expiration date: Unknown) via an unspecified route of administration (age at vaccination 31-year) in left arm on 07Mar2021 at 07:45 AM as dose 2, single for COVID-19 immunization. Medical history included obesity, psoriasis, both from an unknown date and unknown if ongoing. Concomitant medications included triamcinolone taken in two weeks of COVID-19 vaccination, for an unspecified indication, start and stop date were not reported. Historical vaccine included first dose of BNT162B2 administered in left arm on 14Feb2021 at 07:30 AM for COVID-19 immunization. Reported facility type vaccine was school or student health clinic. Patient received no other vaccine in four weeks. Patient had no COVID prior vaccination. The patient not tested COVID post vaccination. On 07Mar2021 at 05:30 PM the patient experienced chills that night, shaking in bed at midnight for about 10 minutes - like a full body shiver that just kept going; felt a kind of cramp or something in his neck at the time too; his right eye was very bloodshot, and had been since Sunday (07mar2021) ... still bloodshot, not sure it had improved ; on 07Mar2021 the patient had a fever maybe starting that night, and that lasted till at least Monday night. May be took until Tuesday or later to feel better. Patient received no treatment for the adverse events. The clinical outcome of the event "fever" was resolved on an unspecified date in Mar2021, while the outcome of other events was unknown.   No follow up attempts are possible. Information about Lot/batch number cannot be obtained.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Dyschezia, Dyspnoea, Fatigue, Gait disturbance, Headache
Clinical narrative: This is a spontaneous report from a contactable other HCP (reported for himself). A 74-year-old male patient received the 2nd dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, solution for injection, batch/lot#: EL9267), at the vaccination age of 74, via an unspecified route of administration, left arm, on Feb 27, 2021, single dose, for COVID-19 immunization. The patient's medical not reported. Prior to the vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not tested for COVID-19. The patient did not receive any other vaccine within 4 weeks prior to COVID-19 vaccination. No allergies reported. The patient received other medications in two weeks. On Mar 3, 2021, at 04:00, patient experienced shortness of breath, tiredness, racing heart, headache and had hard time going to bathroom to defecate; with outcome of recovered Mar 2021. No follow-up attempts possible. No further information expected.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Palpitations
Clinical narrative: This is a spontaneous report from a contactable other HCP (reported for himself). A 74-year-old male patient received the 2nd dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, solution for injection, batch/lot#: EL9267), at the vaccination age of 74, via an unspecified route of administration, left arm, on Feb 27, 2021, single dose, for COVID-19 immunization. The patient's medical not reported. Prior to the vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not tested for COVID-19. The patient did not receive any other vaccine within 4 weeks prior to COVID-19 vaccination. No allergies reported. The patient received other medications in two weeks. On Mar 3, 2021, at 04:00, patient experienced shortness of breath, tiredness, racing heart, headache and had hard time going to bathroom to defecate; with outcome of recovered Mar 2021. No follow-up attempts possible. No further information expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dizziness, Heart rate, Heart rate increased, Pain
Clinical narrative: Uncomfortable in the chest area./ Feels like something is in my chest.; Faster heart rate; Pain in the area; Dizziness/lightheaded; This is a spontaneous report from a contactable consumer (patient). A 39-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN6205, Expiry date: unknown), dose 1 via an unspecified route of administration, administered in Arm Left on 05Mar2021 09:45 (at the age of 39 years) as dose 1, single for covid-19 immunisation. Medical history included drug hypersensitivity to Penicillin. Concomitant medications included colecalciferol (VITAMIN D) and Multi Vitamins. Vaccine facility type was at the event centre. No other vaccine received in four weeks. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient has not been tested for COVID-19. The patient experienced uncomfortable in the chest area, faster heart rate, felt like something was in her chest, pain in the area and dizziness/lightheaded on 06Mar2021. The patient received any treatment for the events was unknown. Adverse event resulted in Doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included heart rate: faster on 06Mar2021. The outcome of events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Movement disorder, Swelling, Tenderness
Clinical narrative: swelling and tenderness in left armpit, the same side as the shot.; swelling and tenderness in left armpit, the same side as the shot.; Discomfort enough to affect movement.; Discomfort enough to affect movement.; This is a spontaneous report from a contactable consumer or other non-health care professional. A 37-years-old non pregnant female patient received (not pregnant at the time of vaccination) bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine, Solution for injection), dose 1 via an unspecified route of administration, administered in arm left on 25Feb2021 10:00 AM(Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation (at the age of 37-year-old). Medical history included asthma and seasonal allergy from an unknown date and unknown if ongoing. Concomitant medication(s) included cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) taken for an unspecified indication, start and stop date were not reported; fluticasone propionate, salmeterol xinafoate (ADVAIR) taken for an unspecified indication, start and stop date were not reported; vitamin d nos (VITAMIN D NOS) taken for an unspecified indication, start and stop date were not reported, these medication was taken in two weeks of vaccination. The patient did not received any other vaccines within 4 weeks prior to the covid 19 vaccine. The patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The patient had no known allergies. On 09Mar2021, the patient experienced, swelling and tenderness in left armpit, the same side as the shot and discomfort enough to affect movement. The patient not received treatment. The events are resulted in doctor or other healthcare professional office/clinic visit. The outcome of the events was not recovered.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Pain in extremity
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 23-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, solution for injection, batch/lot# EN6208 and expiry date not reported), at vaccination age of 23, via an unspecified route of administration, in left arm, on Mar 11, 2021, at 14:30, single dose, for COVID-19 immunization at hospital. The patient was not pregnant at the time of vaccination. The patient's medical history and concomitant medications not reported. The patient did not receive any other vaccine in four weeks. The patient was not diagnosed with COVID-19 prior vaccination. The patient was not tested for COVID-19 post vaccination. On Mar 12, 2021, at 08:00, patient had a sore arm on first day and felt bruised but had no color. The patient did not receive any treatment for the events. The outcome of the event: not recovered. No follow-up attempts possible. No further information expected.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Glossodynia, Hypoaesthesia oral, Rash erythematous
Clinical narrative: Red rash around mouth; Inside lips numb; Tip of tongue sensitive; This is a spontaneous report from a contactable consumer (patient). A 63-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: EN6205), dose 2 via an unspecified route of administration, administered in Arm Right on 07Mar2021 12:00 (at the age of 63-years-old) as a single dose for covid-19 immunization and received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: EL9267), dose 1 via an unspecified route of administration, administered in Arm Right on 14Feb2021 12:00 (at the age of 63-years-old) as a single dose for covid-19 immunization. The patient medical history was not reported. Concomitant medication(s) in two weeks included diltiazem hcl; atorvastatin calcium. The patient did not have any allergies. The patient had no other vaccine within four weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 19Feb2021, the patient experienced red rash around mouth. Inside lips numb. Tip of tongue sensitive. Happened about 5 days after first vaccine, and lasted for a couple of weeks. Then again after second vaccine, 5 days after. Outcome of the event was not recovered, at the time of this report.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Full blood count, Hot flush, Hypoaesthesia, Paraesthesia, Urticaria
Clinical narrative: hives on both legs; hot face with no fever (98.4); numbness and tingling in left side of face and left fingertips; numbness and tingling in left side of face and left fingertips; numbness and tingling in left side of face and left fingertips; This is a spontaneous report from a contactable consumer (patient). A 43-year-old non-pregnant female patient received bnt162b2 (COMIRNATY; solution for injection, Batch/Lot number, Expiration date was not provided), via an intramuscular route of administration in the left arm on 03Mar2021 at 14:45(Age at vaccination 43-years) as dose 2, single for COVID-19 immunization. The patient medical history included Epilepsy, Rare Cancer (PeComa), known allergies: dust, mold, pollen - but not serious and patient has experienced photosensitive hives in the past but they usually resolve within 3-4 hours of coming inside and removing the clothing touching the skin. Patient concomitant medications included bioidentical progesterone, diazepam and HCTZ taken for unknown indication and start and stop date unknown. The patient was not pregnant at the time of vaccination. On 03Mar2021 17:45 the patient experienced 1 hour post injection, hot face with no fever (98.4), numbness and tingling in left side of face and left fingertips which lasted about 3 hours. 8 days post injection - hives on both legs which had been exposed to the sun for about 1 hour -hives resolved with Benadryl but came back when Benadryl wore off. These are still here 48-hours later. Contacted her GP who is running a CBC on her to see what her platelet count is just in case this is a rare side effect. Hives were all over both front thighs and very small spots in random places on arms and torso. The patient visited to clinic, she received treatment with CBC blood draw (results pending) +Benadryl. The outcome of the events was unknown.  No follow up attempts are possible, information about lot/batch number cannot be obtained.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Blister, Pruritus, Scab, Skin discolouration
Clinical narrative: I noticed an itching sensation on the backs of my hands, mostly localized between the thumb and index finger; a very small blister(s); resulting in a tiny scab; very light discoloration on my left hand; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 49-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Batch/Lot Number: EN6200), via an unspecified route of administration, administered in Arm Left on 19Feb2021 11:00 (at the age of 49-years-old) as dose 1, single for COVID-19 immunisation. Medical history included migraine, drug hypersensitivity (Penicillin) from an unknown date and unknown if ongoing. Concomitant medications included sumatriptan succinate (IMITREX), cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), fenofibrate (FENOFIBRATE), magnesium (MAGNESIUM) and ubidecarenone (COQ-10). He did not take any other vaccine in four weeks prior COVID -19 vaccine. He was not diagnosed with COVID prior vaccination and not tested with COVID post vaccination. Within a few days of receiving the first dose, on 20Feb2021, the patient noticed an itching sensation on the backs of his hands, mostly localized between the thumb and index finger. He believed it was worse on my left hand than on my right and there was a very small blister that he inadvertently scratched and opened, resulting in a tiny scab. The itchy sensation persisted at a low grade for a week or two after and the patient was left with very light discoloration on his left hand three weeks later. Initially, he thought it was due to the extreme cold weather, but recently he read about a rash related to the Moderna vaccine. The patient did not received any treatment for all the events. The outcome of events was recovered with sequelae on an unspecified date in 2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Asthenia, Dizziness, Headache
Clinical narrative: Dizzy; splitting headache; weakness; nasaus; loss of taste and smell; loss of taste and smell; This is a spontaneous report from a contactable consumer (patient). A 49-years-old non-pregnant female patient received first dose of bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection, lot number: EP6955) via an unspecified route of administration, administered in arm right on 10Mar2021 14:00 (age at vaccination 49 years and non-pregnant at vaccination) as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history included thyroid, galactosaemia and known allergies included lactose, sulphur, galactose, maybe gluten. Concomitant medications/other medications in two weeks included methimazole, gemfibrozil, progesterone, famotidine. There was no covid prior vaccination. Facility type vaccine was workplace clinic. There was no other vaccine in four weeks. There was no covid tested post vaccination. On 10Mar2021 14:00, the patient experienced dizzy, splitting headache, weakness, nasaus (sp), and the next day loss of taste and smell. Two days out still have most of these symptoms. Adverse event resulted in Doctor or other healthcare professional office/clinic visit. It was unknown if the patient received any treatment for the events. The outcome of the events was unknown.  No follow up attempts are possible. No further information was expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Dizzy; splitting headache; weakness; nasaus; loss of taste and smell; loss of taste and smell; This is a spontaneous report from a contactable consumer (patient). A 49-years-old non-pregnant female patient received first dose of bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection, lot number: EP6955) via an unspecified route of administration, administered in arm right on 10Mar2021 14:00 (age at vaccination 49 years and non-pregnant at vaccination) as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history included thyroid, galactosaemia and known allergies included lactose, sulphur, galactose, maybe gluten. Concomitant medications/other medications in two weeks included methimazole, gemfibrozil, progesterone, famotidine. There was no covid prior vaccination. Facility type vaccine was workplace clinic. There was no other vaccine in four weeks. There was no covid tested post vaccination. On 10Mar2021 14:00, the patient experienced dizzy, splitting headache, weakness, nasaus (sp), and the next day loss of taste and smell. Two days out still have most of these symptoms. Adverse event resulted in Doctor or other healthcare professional office/clinic visit. It was unknown if the patient received any treatment for the events. The outcome of the events was unknown.  No follow up attempts are possible. No further information was expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Crying, Oral pruritus, Paraesthesia oral, Pruritus, SARS-CoV-2 test negative
Clinical narrative: Itching; tingling of the tongue and lips; Weeping; itching of face around mouth; tingling of the tongue and lips; This is a spontaneous report from a contactable consumer (patient herself). A 55-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number was not reported), via an unspecified route of administration, administered in arm left on 10Mar2021 15:00 as dose 1, single for COVID-19 immunization (at the age of 55-year-old). Medical history included asthma, anxiety and hypertension. No known allergies to medications, food, or other products. The patient's concomitant medications were not reported. The patient did not had any other vaccine in four weeks. The patient did not had COVID prior vaccination. On 10Mar2021 16:00, the patient experienced itching, tingling of the tongue and lips, weeping and itching of face around mouth. The patient did not took any treatment for adverse events. The patient was not diagnosed with COVID-19 prior to vaccination and since the vaccination, the patient been tested for COVID-19. The patient underwent lab tests and procedures which included sars-cov-2 test: negative (mouth swab). The outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Extreme itching on neck & chest, arms & legs; This is a spontaneous report from a contactable consumer (patient). A 77-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number was not reported) via an unspecified route of administration on 23Feb2021 at 12:45 (at the age of 77-years-old) as a single dose for covid-19 immunization. The patient medical history was not reported. Prior to vaccination, the patient was not diagnosed with covid-19. Post vaccination, the patient had not been tested for covid-19. Known allergies were not known. The patient did not receive any other vaccine in four weeks. Concomitant medications received in two weeks included lisinopril (LISINOPRIL) and metoprolol (METOPROLOL) both taken for an unspecified indication, start and stop date were not reported. The patient experienced extreme itching on neck, chest, arms, and legs on 23Feb2021. The patient did not receive any treatment. She was not sure whether to have second vaccination on 16Mar2021. The outcome of the event was not resolved.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Dizziness, Epistaxis
Clinical narrative: bruise; dizzy; nose bleed; This is a spontaneous report from a contactable consumer. This female consumer of unknown age reported for herself that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration on 09Mar2021 as dose 1, single for COVID-19 immunization. The patient's medical history included lung problem. The patient's concomitant medications were not reported. On 10Mar2021, the next day she noticed a bruise (green circle) on her hand, not where the vaccine was given. She also stated that she was dizzy and had a nosebleed upon waki ng up. The consumer wanted to know that were these normal events and should she still get the second dose. If she did not have a severe allergic reaction with the first dose, was she safe to take the second dose. The vaccination site only watched them for 10 minutes after the first dose. The event outcome was unknown. The caller also wanted to know about reports of death caused by the vaccine and her auntie felt like she had the flu after the second dose.  No follow-up attempts were possible; information about lot/batch number could not be obtained.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Dizziness, Fatigue, Flushing, Lethargy
Clinical narrative: Lightheaded when standing or stopped; flush; coughing; tiredness; Lethargic; This is a spontaneous report from a contactable consumer(patient). A 63-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: Not reported) via an unspecified route of administration, administered in right arm on11Mar2021 04:00 PM as DOSE 1, SINGLE for COVID-19 immunization (age at vaccination 63 years). The patients medical history was not reported. Atvastin was taken as concomitant other medications in two weeks for an unspecified reason and an unknown start date and stop date. No other vaccine in four weeks was reported. The patient had Covid prior vaccination. No Covid tested post vaccination. No Known allergies. On 12Mar2021 12:00 PM the patient experienced Lightheaded when standing or stopped, flush, coughing, tiredness, lethargic. No treatment received for the events. The outcome of the event was recovering.  Information about lot/batch number cannot be obtained. No further information expected.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Body temperature, Headache, Nausea
Clinical narrative: 102 Fever; headache; joint pain; back pain; nausea; This is a spontaneous report from a contactable consumer (patient) via Covid-19 Adverse Event Self-Reporting Solution). A 19-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 11Mar2021 08:15 (lot number: EN6203; expiry date: unknown) at the age of 19-years-old, as dose 1, single for COVID-19 immunisation. Medical history included Crohn's disease, polycystic ovarian syndrome (PCOS), migraines, and epilepsy. There were no concomitant medications. The patient previously received Cefcil and experienced allergies. The patient was not diagnosed with Covid-19 prior vaccination. The patient was not pregnant at the time of vaccination. The vaccine was administered in Public Health Clinic/Veterans Administration facility. The patient did not receive other vaccines in four weeks, or other medications in two weeks. On 11Mar2021 at 23:00, the patient experienced 102 fever, headache, joint pain, back pain, and nausea. The patient did not receive treatment for the events. Outcome of the events was recovering. The patient has not been tested for Covid-19 post vaccination.   No follow-up attempts are possible. No further information is expected.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: 102 Fever; headache; joint pain; back pain; nausea; This is a spontaneous report from a contactable consumer (patient) via Covid-19 Adverse Event Self-Reporting Solution). A 19-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 11Mar2021 08:15 (lot number: EN6203; expiry date: unknown) at the age of 19-years-old, as dose 1, single for COVID-19 immunisation. Medical history included Crohn's disease, polycystic ovarian syndrome (PCOS), migraines, and epilepsy. There were no concomitant medications. The patient previously received Cefcil and experienced allergies. The patient was not diagnosed with Covid-19 prior vaccination. The patient was not pregnant at the time of vaccination. The vaccine was administered in Public Health Clinic/Veterans Administration facility. The patient did not receive other vaccines in four weeks, or other medications in two weeks. On 11Mar2021 at 23:00, the patient experienced 102 fever, headache, joint pain, back pain, and nausea. The patient did not receive treatment for the events. Outcome of the events was recovering. The patient has not been tested for Covid-19 post vaccination.   No follow-up attempts are possible. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Vaccination site pain
Clinical narrative: elbow joint pain; Mild pain at area of injection; This is a spontaneous report from a contactable consumer (patient). A 51-year-old non-pregnant female patient received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine), via an unspecified route of administration, administered in the left arm on 12Mar2021 at 14:00 (Lot Number: ENG6202) as dose 1, single for COVID-19 immunization. The patient did not have any medical history and had no known allergies. The patient did not have COVID prior to vaccination. The patient was not tested for COVID post vaccination. Concomitant medications included vitamin b complex (manufacturer unknown); curcuma longa (TURMERIC, manufacturer unknown) and cetirizine (manufacturer unknown), all taken for an unspecified indication, start and stop date were not reported. On 12Mar2021 at 17:00, the patient experienced mild pain at area of injection and elbow joint pain. The patient did not receive treatment for the events. The outcome of the events was not recovered.   No follow-up attempts are possible. No further information is expected.